Phesi

Executive Summary

Phesi is a US-based clinical trial intelligence company that leverages AI-powered data analytics and the world's largest curated clinical trials database, containing real-world data from over 300 million patients, to accelerate drug development. By optimizing protocol design, site selection, and patient recruitment, Phesi's platform aims to reduce trial costs, timelines, and failure rates for biopharmaceutical companies. Founded in 2007 and headquartered in Boston, Phesi operates at the intersection of AI and digital health, providing actionable insights that enhance the efficiency of clinical trials. The company's technology addresses critical pain points in drug development, enabling sponsors to make data-driven decisions that improve trial success probabilities. With a focus on maximizing the use of historical and real-world evidence, Phesi is positioned as a key enabler in the shift toward more efficient, patient-centric clinical research, potentially reducing the high costs associated with bringing new therapies to market.

Upcoming Catalysts (preview)

• Q3 2026New AI-Powered Protocol Design Module Launch80% success
• Q4 2026Strategic Partnership with Top-20 Pharma Company60% success
• H1 2027Series C Funding Round Announcement70% success